AHR and metabolic dysfunction-associated steatohepatitis: By using pharmacological and genetic approaches, we demonstrate that the novel derivative activates the AhR in the intestine and metabolic tissues, and is beneficial in reducing inflammation in murine models of intestinal inflammation and NASH.